Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Georgetown University Hospital
mi
from
Washington,
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Georgetown University Hospital
mi
from
Washington,
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
University of Miami / Center for Liver Diseases
mi
from
Miami, FL
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
University of Miami / Center for Liver Diseases
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Tampa General Hospital
mi
from
Tampa, FL
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Tampa General Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
University of Chicago Medical Center
mi
from
Chicago, IL
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Tulane University Health Science Center
mi
from
New Orleans, LA
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Tulane University Health Science Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
University of Maryland
mi
from
Baltimore, MD
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Henry Ford Hospital / Department of Gastroenterology
mi
from
Detroit, MI
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Henry Ford Hospital / Department of Gastroenterology
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Concorde Medical Group
mi
from
New York, NY
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Concorde Medical Group
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
NYU Medical Center
mi
from
New York, NY
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
NYU Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Univ of Rochester Medical Center
mi
from
Rochester, NY
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
New York Medical College / Westchester Medical Center
mi
from
Valhalla, NY
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
New York Medical College / Westchester Medical Center
mi
from
Valhalla, NY
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
University of Cincinnati / Division of Digestive Diseases
mi
from
Cincinnati, OH
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
University of Cincinnati / Division of Digestive Diseases
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Cleveland Clinic
mi
from
Cleveland, OH
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
U.T. Southwestern Medical Center
mi
from
Dallas, TX
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Baylor College of Medicine-St. Luke's Episcopal Hospital
mi
from
Houston, TX
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Baylor College of Medicine-St. Luke's Episcopal Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
University of Virginia Health System
mi
from
Charlottesville, VA
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
University of Virginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
HIV/STI Prevention for Adolescents With Substance Use Disorders in Treatment
HIV/STI Prevention for Adolescents With Substance Use Disorders in Treatment
Status: Enrolling
Updated:  8/27/2015
St. Luke's Roosevelt Hospital
mi
from
New York, NY
HIV/STI Prevention for Adolescents With Substance Use Disorders in Treatment
HIV/STI Prevention for Adolescents With Substance Use Disorders in Treatment
Status: Enrolling
Updated: 8/27/2015
St. Luke's Roosevelt Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP)
Extending Ketamine's Effects in Obsessive-Compulsive Disorder (OCD) With Exposure and Response Prevention (EX/RP)
Status: Enrolling
Updated:  8/27/2015
New York State Psychiatric Insitute
mi
from
New York, NY
Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP)
Extending Ketamine's Effects in Obsessive-Compulsive Disorder (OCD) With Exposure and Response Prevention (EX/RP)
Status: Enrolling
Updated: 8/27/2015
New York State Psychiatric Insitute
mi
from
New York, NY
Click here to add this to my saved trials
IV Cocaine Abuse: A Laboratory Model - 1
IV Cocaine Abuse: A Laboratory Model
Status: Enrolling
Updated:  8/27/2015
Columbia University
mi
from
New York, NY
IV Cocaine Abuse: A Laboratory Model - 1
IV Cocaine Abuse: A Laboratory Model
Status: Enrolling
Updated: 8/27/2015
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
IV Cocaine Abuse: A Laboratory Model - 2
IV Cocaine Abuse: A Laboratory Model
Status: Enrolling
Updated:  8/27/2015
Columbia University
mi
from
New York, NY
IV Cocaine Abuse: A Laboratory Model - 2
IV Cocaine Abuse: A Laboratory Model
Status: Enrolling
Updated: 8/27/2015
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
IV Cocaine Abuse: A Laboratory Model - 3
IV Cocaine Abuse: A Laboratory Model
Status: Enrolling
Updated:  8/27/2015
Columbia University
mi
from
New York, NY
IV Cocaine Abuse: A Laboratory Model - 3
IV Cocaine Abuse: A Laboratory Model
Status: Enrolling
Updated: 8/27/2015
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
Allogeneic Hematopoietic Stem Cell Transplantation for Induction of Mixed Hematopoietic Chimerism in Patients Infected With Human Immunodeficiency Virus-1 Using a Non-Marrow Ablative Conditioning Regimen Containing Total Body Irradiation in Combination With Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil
Status: Enrolling
Updated:  8/28/2015
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
Allogeneic Hematopoietic Stem Cell Transplantation for Induction of Mixed Hematopoietic Chimerism in Patients Infected With Human Immunodeficiency Virus-1 Using a Non-Marrow Ablative Conditioning Regimen Containing Total Body Irradiation in Combination With Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil
Status: Enrolling
Updated: 8/28/2015
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Evaluation of GSK561679 in Women With Post-Traumatic Stress Disorder
Evaluation of the Efficacy of the CRF1 Antagonist GSK561679 in Women With Post-traumatic Stress Disorder
Status: Enrolling
Updated:  8/31/2015
Stress and Health Research Program, San Francisco VA Medical Center, University of California San Francisco
mi
from
San Francisco, CA
Evaluation of GSK561679 in Women With Post-Traumatic Stress Disorder
Evaluation of the Efficacy of the CRF1 Antagonist GSK561679 in Women With Post-traumatic Stress Disorder
Status: Enrolling
Updated: 8/31/2015
Stress and Health Research Program, San Francisco VA Medical Center, University of California San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Evaluation of GSK561679 in Women With Post-Traumatic Stress Disorder
Evaluation of the Efficacy of the CRF1 Antagonist GSK561679 in Women With Post-traumatic Stress Disorder
Status: Enrolling
Updated:  8/31/2015
Baylor College of Medicine
mi
from
Houston, TX
Evaluation of GSK561679 in Women With Post-Traumatic Stress Disorder
Evaluation of the Efficacy of the CRF1 Antagonist GSK561679 in Women With Post-traumatic Stress Disorder
Status: Enrolling
Updated: 8/31/2015
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluation of GSK561679 in Women With Post-Traumatic Stress Disorder
Evaluation of the Efficacy of the CRF1 Antagonist GSK561679 in Women With Post-traumatic Stress Disorder
Status: Enrolling
Updated:  8/31/2015
Emory University
mi
from
Atlanta, GA
Evaluation of GSK561679 in Women With Post-Traumatic Stress Disorder
Evaluation of the Efficacy of the CRF1 Antagonist GSK561679 in Women With Post-traumatic Stress Disorder
Status: Enrolling
Updated: 8/31/2015
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Evaluation of GSK561679 in Women With Post-Traumatic Stress Disorder
Evaluation of the Efficacy of the CRF1 Antagonist GSK561679 in Women With Post-traumatic Stress Disorder
Status: Enrolling
Updated:  8/31/2015
Mount Sinai School of Medicine
mi
from
New York, NY
Evaluation of GSK561679 in Women With Post-Traumatic Stress Disorder
Evaluation of the Efficacy of the CRF1 Antagonist GSK561679 in Women With Post-traumatic Stress Disorder
Status: Enrolling
Updated: 8/31/2015
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression
Adjunctive Lisdexamfetamine in Bipolar Depression
Status: Enrolling
Updated:  8/31/2015
Lindner Center of HOP
mi
from
Mason, OH
Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression
Adjunctive Lisdexamfetamine in Bipolar Depression
Status: Enrolling
Updated: 8/31/2015
Lindner Center of HOP
mi
from
Mason, OH
Click here to add this to my saved trials
Autoregulation Assessment During Liver Transplantation
Non-Invasive Assessment of Cerebral Blood Flow Autoregulation in Patients Undergoing Liver Transplantation
Status: Enrolling
Updated:  8/31/2015
Johns Hopkins Hospital
mi
from
Baltimore, MD
Autoregulation Assessment During Liver Transplantation
Non-Invasive Assessment of Cerebral Blood Flow Autoregulation in Patients Undergoing Liver Transplantation
Status: Enrolling
Updated: 8/31/2015
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Decision-Making in Bipolar Disorder
Decision-Making in Bipolar Disorder
Status: Enrolling
Updated:  8/31/2015
Emory University Mood and Anxiety Disorders Program
mi
from
Atlanta, GA
Decision-Making in Bipolar Disorder
Decision-Making in Bipolar Disorder
Status: Enrolling
Updated: 8/31/2015
Emory University Mood and Anxiety Disorders Program
mi
from
Atlanta, GA
Click here to add this to my saved trials
Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression
A Randomized, Blinded, Comparison of Asenapine and Placebo as Adjunctive Treatment in Patients With Non-Psychotic Major Depressive Disorder Incompletely Responsive to Antidepressant Monotherapy
Status: Enrolling
Updated:  8/31/2015
Georgia Health Sciences University
mi
from
Augusta, GA
Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression
A Randomized, Blinded, Comparison of Asenapine and Placebo as Adjunctive Treatment in Patients With Non-Psychotic Major Depressive Disorder Incompletely Responsive to Antidepressant Monotherapy
Status: Enrolling
Updated: 8/31/2015
Georgia Health Sciences University
mi
from
Augusta, GA
Click here to add this to my saved trials
Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression
A Randomized, Blinded, Comparison of Asenapine and Placebo as Adjunctive Treatment in Patients With Non-Psychotic Major Depressive Disorder Incompletely Responsive to Antidepressant Monotherapy
Status: Enrolling
Updated:  8/31/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression
A Randomized, Blinded, Comparison of Asenapine and Placebo as Adjunctive Treatment in Patients With Non-Psychotic Major Depressive Disorder Incompletely Responsive to Antidepressant Monotherapy
Status: Enrolling
Updated: 8/31/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression
A Randomized, Blinded, Comparison of Asenapine and Placebo as Adjunctive Treatment in Patients With Non-Psychotic Major Depressive Disorder Incompletely Responsive to Antidepressant Monotherapy
Status: Enrolling
Updated:  8/31/2015
Carolina Behavioral Care
mi
from
Durham, NC
Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression
A Randomized, Blinded, Comparison of Asenapine and Placebo as Adjunctive Treatment in Patients With Non-Psychotic Major Depressive Disorder Incompletely Responsive to Antidepressant Monotherapy
Status: Enrolling
Updated: 8/31/2015
Carolina Behavioral Care
mi
from
Durham, NC
Click here to add this to my saved trials
Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression
A Randomized, Blinded, Comparison of Asenapine and Placebo as Adjunctive Treatment in Patients With Non-Psychotic Major Depressive Disorder Incompletely Responsive to Antidepressant Monotherapy
Status: Enrolling
Updated:  8/31/2015
Brody School of Medicine at East Carolina University
mi
from
Greenville, NC
Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression
A Randomized, Blinded, Comparison of Asenapine and Placebo as Adjunctive Treatment in Patients With Non-Psychotic Major Depressive Disorder Incompletely Responsive to Antidepressant Monotherapy
Status: Enrolling
Updated: 8/31/2015
Brody School of Medicine at East Carolina University
mi
from
Greenville, NC
Click here to add this to my saved trials
Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression
A Randomized, Blinded, Comparison of Asenapine and Placebo as Adjunctive Treatment in Patients With Non-Psychotic Major Depressive Disorder Incompletely Responsive to Antidepressant Monotherapy
Status: Enrolling
Updated:  8/31/2015
North Carolina Psychiatric Research Center
mi
from
Raleigh, NC
Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression
A Randomized, Blinded, Comparison of Asenapine and Placebo as Adjunctive Treatment in Patients With Non-Psychotic Major Depressive Disorder Incompletely Responsive to Antidepressant Monotherapy
Status: Enrolling
Updated: 8/31/2015
North Carolina Psychiatric Research Center
mi
from
Raleigh, NC
Click here to add this to my saved trials
Omega-3 Dietary Supplements in Schizophrenia
Detecting Which Patients With Schizophrenia Will Improve With Omega-3 Treatment
Status: Enrolling
Updated:  8/31/2015
The Zucker Hillside Hospital
mi
from
Glen Oaks, NY
Omega-3 Dietary Supplements in Schizophrenia
Detecting Which Patients With Schizophrenia Will Improve With Omega-3 Treatment
Status: Enrolling
Updated: 8/31/2015
The Zucker Hillside Hospital
mi
from
Glen Oaks, NY
Click here to add this to my saved trials
Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia
Interventions for Adherence to Oral Antipsychotic Medications in Schizophrenia
Status: Enrolling
Updated:  9/1/2015
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia
Interventions for Adherence to Oral Antipsychotic Medications in Schizophrenia
Status: Enrolling
Updated: 9/1/2015
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers
A Pivotal, Phase 1, Open-Label, Randomized, Crossover, Single-Dose, Comparative Bioavailability Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers
Status: Enrolling
Updated:  9/1/2015
Worldwide Clinical Trials Early Phase Services
mi
from
San Antonio, TX
Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers
A Pivotal, Phase 1, Open-Label, Randomized, Crossover, Single-Dose, Comparative Bioavailability Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers
Status: Enrolling
Updated: 9/1/2015
Worldwide Clinical Trials Early Phase Services
mi
from
San Antonio, TX
Click here to add this to my saved trials
Enhanced Smoking Cessation Intervention for Smokers Exposed to the World Trade Center (WTC) Disaster
Enhanced Smoking Cessation Intervention for Smokers Exposed to the WTC Disaster
Status: Enrolling
Updated:  9/1/2015
Stony Brook University, Putnam Hall
mi
from
Stony Brook, NY
Enhanced Smoking Cessation Intervention for Smokers Exposed to the World Trade Center (WTC) Disaster
Enhanced Smoking Cessation Intervention for Smokers Exposed to the WTC Disaster
Status: Enrolling
Updated: 9/1/2015
Stony Brook University, Putnam Hall
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Implementation of an Evidence Based Post-Traumatic Stress Disorder (PTSD) Treatment in Public Sector Settings
Implementation of an Evidence Based PTSD Treatment in Public Sector Settings
Status: Enrolling
Updated:  9/2/2015
VA Palo Alto Health Care System, NC-PTSD, Dissemination and Training Division
mi
from
Palo Alto, CA
Implementation of an Evidence Based Post-Traumatic Stress Disorder (PTSD) Treatment in Public Sector Settings
Implementation of an Evidence Based PTSD Treatment in Public Sector Settings
Status: Enrolling
Updated: 9/2/2015
VA Palo Alto Health Care System, NC-PTSD, Dissemination and Training Division
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Implementation of an Evidence Based Post-Traumatic Stress Disorder (PTSD) Treatment in Public Sector Settings
Implementation of an Evidence Based PTSD Treatment in Public Sector Settings
Status: Enrolling
Updated:  9/2/2015
Christie's Place
mi
from
San Diego, CA
Implementation of an Evidence Based Post-Traumatic Stress Disorder (PTSD) Treatment in Public Sector Settings
Implementation of an Evidence Based PTSD Treatment in Public Sector Settings
Status: Enrolling
Updated: 9/2/2015
Christie's Place
mi
from
San Diego, CA
Click here to add this to my saved trials
Implementation of an Evidence Based Post-Traumatic Stress Disorder (PTSD) Treatment in Public Sector Settings
Implementation of an Evidence Based PTSD Treatment in Public Sector Settings
Status: Enrolling
Updated:  9/2/2015
University of Connecticut Health Center
mi
from
Farmington, CT
Implementation of an Evidence Based Post-Traumatic Stress Disorder (PTSD) Treatment in Public Sector Settings
Implementation of an Evidence Based PTSD Treatment in Public Sector Settings
Status: Enrolling
Updated: 9/2/2015
University of Connecticut Health Center
mi
from
Farmington, CT
Click here to add this to my saved trials
Implementation of an Evidence Based Post-Traumatic Stress Disorder (PTSD) Treatment in Public Sector Settings
Implementation of an Evidence Based PTSD Treatment in Public Sector Settings
Status: Enrolling
Updated:  9/2/2015
Grady Health System
mi
from
Atlanta, GA
Implementation of an Evidence Based Post-Traumatic Stress Disorder (PTSD) Treatment in Public Sector Settings
Implementation of an Evidence Based PTSD Treatment in Public Sector Settings
Status: Enrolling
Updated: 9/2/2015
Grady Health System
mi
from
Atlanta, GA
Click here to add this to my saved trials
Implementation of an Evidence Based Post-Traumatic Stress Disorder (PTSD) Treatment in Public Sector Settings
Implementation of an Evidence Based PTSD Treatment in Public Sector Settings
Status: Enrolling
Updated:  9/2/2015
Cambridge Health Alliance
mi
from
Cambridge, MA
Implementation of an Evidence Based Post-Traumatic Stress Disorder (PTSD) Treatment in Public Sector Settings
Implementation of an Evidence Based PTSD Treatment in Public Sector Settings
Status: Enrolling
Updated: 9/2/2015
Cambridge Health Alliance
mi
from
Cambridge, MA
Click here to add this to my saved trials
Implementation of an Evidence Based Post-Traumatic Stress Disorder (PTSD) Treatment in Public Sector Settings
Implementation of an Evidence Based PTSD Treatment in Public Sector Settings
Status: Enrolling
Updated:  9/2/2015
New York University- Bellevue
mi
from
New York, NY
Implementation of an Evidence Based Post-Traumatic Stress Disorder (PTSD) Treatment in Public Sector Settings
Implementation of an Evidence Based PTSD Treatment in Public Sector Settings
Status: Enrolling
Updated: 9/2/2015
New York University- Bellevue
mi
from
New York, NY
Click here to add this to my saved trials